+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glucagon Like Peptide 1 Agonist"

Endocrinology Drugs Market by Therapy Area, Distribution Channel, and By Region - Product Thumbnail Image

Endocrinology Drugs Market by Therapy Area, Distribution Channel, and By Region

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Anti-diabetic Drugs Market - Product Thumbnail Image

Anti-diabetic Drugs Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Diabetes Care Drugs Market Analysis & Forecast to 2023-2033: Market By Drugs; By Type; By Rote of Administration; By End-user; and By Region - Product Thumbnail Image

Diabetes Care Drugs Market Analysis & Forecast to 2023-2033: Market By Drugs; By Type; By Rote of Administration; By End-user; and By Region

  • Report
  • August 2023
  • 145 Pages
  • Global
From
Thyroid Gland Disorders Treatment Market Analysis & Forecast to 2023-2033: Market By Indication; By Route of Administration; By Distribution Channel; and by Region - Product Thumbnail Image

Thyroid Gland Disorders Treatment Market Analysis & Forecast to 2023-2033: Market By Indication; By Route of Administration; By Distribution Channel; and by Region

  • Report
  • July 2023
  • 145 Pages
  • Global
From
Glucagon-like Peptide-1 (GLP-1) Agonists Market Size, Target Population, Competitive Landscape & Market Forecast - 2034 - Product Thumbnail Image

Glucagon-like Peptide-1 (GLP-1) Agonists Market Size, Target Population, Competitive Landscape & Market Forecast - 2034

  • Report
  • January 2024
  • 120 Pages
  • Global
From
Diabetic Kidney Disease (DKD) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Diabetic Kidney Disease (DKD) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • January 2024
  • 189 Pages
  • Global
From
SAXENDA (Liraglutide), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SAXENDA (Liraglutide), Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Type 2 Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Diabetes - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
Post-Bariatric Hypoglycemia - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Post-Bariatric Hypoglycemia - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Hypertriglyceridemia - Pipeline Insight, 2025 - Product Thumbnail Image

Hypertriglyceridemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Prader Willi Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Prader Willi Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hypoglycemia- Pipeline Insight, 2025 - Product Thumbnail Image

Hypoglycemia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Semaglutide Market Size, Emerging Insight, and Forecast to 2032 - Product Thumbnail Image

Semaglutide Market Size, Emerging Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
Indonesia Diabetes Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

Indonesia Diabetes Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • January 2026
  • 70 Pages
  • Indonesia
From
Japan Diabetes Drugs And Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Thumbnail Image

Japan Diabetes Drugs And Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • May 2025
  • 70 Pages
  • Japan
From
Semaglutide - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Thumbnail Image

Semaglutide - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • July 2024
  • 70 Pages
  • Global
From
Trulicity - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Thumbnail Image

Trulicity - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • July 2024
  • 70 Pages
  • Global
From
Loading Indicator

The Glucagon Like Peptide 1 Agonist (GLP-1) market is a subset of the larger diabetes drugs market. GLP-1 agonists are a class of drugs used to treat type 2 diabetes, and are designed to mimic the effects of the hormone glucagon-like peptide-1 (GLP-1). GLP-1 agonists work by stimulating the release of insulin, reducing the amount of glucose in the blood, and slowing the rate of gastric emptying. GLP-1 agonists are typically administered via injection, and are used in combination with other diabetes medications. The GLP-1 agonist market is highly competitive, with a number of major pharmaceutical companies offering products. These include Novo Nordisk, Eli Lilly, Sanofi, AstraZeneca, and Boehringer Ingelheim. Show Less Read more